Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 1 + 1

That is possible, but remember newbies will also look back and see what our EPS, revenues and PPS has shown over the last 1-2 years too....add to that the request for more dilution in the OS and a possible RS coming down the line and many newbies IMO will wait for more substanial information regarding the items I've mentioned.

Long timers and readers of this board will tend to buy more and thus pop the price some when reexams are complete, but once again, to hold on that pop we will substantive, meaningful info for newcomers to make that jump in...esp. in light of the current market conditions.

And I think we've proven that many times already when new licenses are announced. We who are already sharehowners are always looking for that price appreciation to occur when those license PR's come out...it seldom happens though for lack of revenue on each and future projections of EPS etc.etc....these are the hard info's many newcomers will want to see first...not having to discern what is what, 3 months after the fact.... JMHO

Share
New Message
Please login to post a reply